Sees total revenue increasing by high-single digit percentage. See core tax rate between 18%-22%
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca reports Q2 core EPS $2.17, up 12% at CER
- AZN Earnings: Drugs Giant AstraZeneca (AZN) Zooms Higher on Cancer-Fighting Demand
- Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
- AstraZeneca’s Phase 4 Study on Trastuzumab Deruxtecan: Safety Insights for Indian Patients
- AstraZeneca’s Innovative Study on Bladder Cancer: A Potential Game-Changer